Search - tctmd.com

Displaying 901 - 920 of 924

Sort: Relevancy | Date

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

Jason Kahn

April 05, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Caitlin E. Cox

April 03, 2011

News Industry News

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

April 03, 2011

News Industry News

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC

April 03, 2011

News Industry News

Medtronic Mosaic® Heart Valve Demonstrates Long-Term Durability Up to 12 Years in International Study

February 27, 2011

News Industry News

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

February 23, 2011

News Industry News

Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes

February 17, 2011

News Industry News

Medtronic Revises Design of CoreValve® U.S. Pivotal Trial

January 17, 2011

News Industry News

JenaValve™ reports significant clinical milestone: first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis

January 17, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

Video

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

September 28, 2019

Video

TVT 2019: Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

June 15, 2019

Video

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

June 14, 2019

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Advertisement

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

PARTNER: TAVI Cost Effective Compared With Standard Care

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC

Medtronic Mosaic® Heart Valve Demonstrates Long-Term Durability Up to 12 Years in International Study

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes

Medtronic Revises Design of CoreValve® U.S. Pivotal Trial

JenaValve™ reports significant clinical milestone: first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis

NEJM Letters Take on PARTNER Trial

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

TVT 2019: Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content